Metabolic Effects of Empagliflozin in Heart Failure A Randomized, Double-Blind, and Placebo-Controlled Trial (Empire HF Metabolic)
Research output: Contribution to journal › Letter › Research › peer-review
Original language | English |
---|---|
Journal | Circulation |
Volume | 143 |
Issue number | 22 |
Pages (from-to) | 2208-2210 |
Number of pages | 3 |
ISSN | 0009-7322 |
DOIs | |
Publication status | Published - 2021 |
- body composition, diabetes mellitus, type 2, empagliflozin, heart failure, insulin resistance, sodium-glucose transporter 2 inhibitors, REDUCED EJECTION FRACTION
Research areas
ID: 271613089